Sources listed; review status not recorded
Almost everyone who has ever had their heart health "checked" got the same thing: a lipid panel with four numbers -- total cholesterol, LDL, HDL, triglycerides -- a note that the LDL was "normal," and no explanation of what any of it meant. And for a lot of people that is where the story ends: normal number, no idea whether the real risk was measured at all. Here is the part the standard panel leaves out. The LDL cholesterol on your report is not a count of anything that lodges in an artery -- it is an estimate of how much cholesterol is packed inside your LDL particles. But the artery wall does not care how full each particle is; it cares how MANY particles keep bumping into it. Once you see that distinction, the whole panel starts to make sense -- and so does why two markers most people have never been offered, ApoB and Lp(a), tell you more than the number they were handed.
The panel you probably got, and what it leaves out
Start with the test itself, because the gap is right there in what was ordered. The standard lipid panel reports four things: total cholesterol, LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), and triglycerides. The number everyone fixates on is LDL-C. Here is what LDL-C actually is: cholesterol is not water-soluble, so your body ships it around the bloodstream inside particles -- little protein-wrapped boats. LDL-C is an estimate of the total cholesterol CARGO being carried inside all your LDL boats combined. It is a measure of the cargo, not a count of the boats. That distinction is the whole game, because it is the boats -- the particles -- that burrow into an artery wall and start the process. Two people can carry the same total cargo in very different numbers of boats: one person in a few large, cholesterol-stuffed particles, another in many small, half-empty ones. Same LDL-C on the printout, very different number of particles knocking against the vessel wall. The standard panel cannot tell those two people apart, because it never counts the boats. Our view, stated as our own: a standard lipid panel is a reasonable place to start and a poor place to stop. It answers one question -- roughly how much cholesterol cargo is in circulation -- and leaves the more useful question, how many atherogenic particles am I actually carrying, completely untouched.
ApoB: counting the particles, not the cargo
If LDL-C measures the cargo, ApoB counts the boats -- and that turns out to be the better question. ApoB is short for apolipoprotein B. Here is the elegant part of the biology: every one of the particles that can lodge in an artery wall -- LDL, VLDL, IDL, and Lp(a) -- carries exactly ONE ApoB molecule on its surface. One particle, one ApoB. So a single ApoB blood test is a direct headcount of every atherogenic particle you have, all of them, at once. LDL-C estimates the contents; ApoB counts the containers. And the headcount predicts better. In over 41,000 UK Biobank participants followed for a decade, ApoB predicted cardiovascular events more consistently than LDL particle number when the two disagreed.[1] A separate 20-year cohort found the same thing: when ApoB and the standard cholesterol markers pointed in different directions, ApoB better reflected long-term risk.[2] This is why a person can be told their "cholesterol is normal" -- a fine LDL-C -- while their ApoB says they are carrying a high number of particles the standard number simply could not see. Our view, and this is the crux of the page: a normal LDL-C sitting on top of a high ApoB is not a paradox, it is the predictable result of measuring cargo instead of counting particles. When you want to know your real particle burden, ApoB is the number to ask for -- and it is a cheap, widely available blood test that most standard panels still do not include by default.
Lp(a): the inherited risk a standard panel never orders
The second marker most people have never been offered is the one you are largely born with. Lp(a) -- lipoprotein(a), said "L-P-little-a" -- is an LDL-like particle with an extra protein strand wrapped around it. What makes it different from everything else on the panel is that its level is set overwhelmingly by your genes and is largely independent of diet, exercise and the usual lifestyle levers. A review of the field describes Lp(a) as a genetically driven, largely diet-independent cardiovascular risk factor distinct from LDL cholesterol.[3] In other words, you can eat perfectly and still carry a high Lp(a), because it was written into your inheritance, not your habits. That is exactly why it is worth measuring once. Because it is stable across life, a single Lp(a) test tells you whether you carry an inherited layer of risk that no standard panel would ever reveal -- information that changes how seriously the rest of the picture should be taken, and information a clinician interprets rather than something to act on alone. Our view, kept honest: Lp(a) is the clearest example on this page of why "my cholesterol is fine" can be an incomplete sentence. It is not moved much by the diet-and-movement loop the rest of this post is about -- so we name it plainly as a measure-once, know-your-baseline marker, not something we would ever imply a supplement or a smoothie fixes.
The triglyceride-to-HDL ratio: a quiet window on insulin resistance
Two numbers already on your standard panel, read as a ratio, tell you something the panel was not designed to say out loud. Divide your triglycerides by your HDL cholesterol and you get the triglyceride-to-HDL ratio. Its usefulness is that it tracks with insulin resistance -- the state in which cells respond sluggishly to insulin, the upstream engine of a great deal of metabolic and cardiovascular trouble. In a study of non-diabetic overweight adults, fasting triglycerides and the triglyceride-to-HDL ratio identified insulin-resistant individuals about as well as more elaborate testing.[4] A high ratio is the fingerprint of the small, dense LDL particles and the metabolic pattern that go with insulin resistance. This is the bridge between your lipid panel and your blood sugar, and it costs nothing extra -- the two numbers are already sitting on the report. A rising triglyceride-to-HDL ratio is one of the earliest, cheapest hints that the metabolic side of cardiovascular health deserves attention, often long before a fasting glucose looks abnormal. Our view: this ratio is the most underused free information on a standard panel. It reframes "cholesterol" as partly a blood-sugar story -- which is why the diet levers later on this page lean as hard on insulin sensitivity as on lipids.
hs-CRP and homocysteine: inflammation and methylation
Two more markers fill in causes the lipid numbers cannot, and both come with an honest caveat. hs-CRP -- high-sensitivity C-reactive protein -- is a marker of low-grade inflammation in the body. It matters here because atherosclerosis is not just a plumbing problem of cholesterol build-up; it is also an inflammatory process in the vessel wall. In nearly 28,000 women followed for years, baseline hs-CRP was a stronger predictor of cardiovascular events than LDL cholesterol.[5] The honest caveat is that hs-CRP is non-specific -- it rises with any inflammation, from a cold to a sore knee -- so it is read as a trend and in context, never as a stand-alone verdict. Homocysteine is an amino acid your body is meant to clear, and clearing it depends on methylation -- a cellular housekeeping process run by the B vitamins B6, folate (B9) and B12. When those cofactors run short, homocysteine climbs, which is why an elevated level is read partly as a methylation-status signal. A review of decades of randomized trials confirms that B6, B9 and B12 lower blood homocysteine through their roles as methylation cofactors.[6] But here is the honesty the marker demands: lowering homocysteine with B vitamins has NOT reliably reduced cardiovascular events in large trials -- a five-year vascular-disease trial lowered homocysteine with folic acid, B6 and B12 and still saw no drop in events.[13] So homocysteine is a useful read on methylation and B-vitamin status, and not a number to chase for its own sake. Our view: hs-CRP and homocysteine earn their place because they point at mechanisms -- inflammation and methylation -- that the lipid panel is blind to. We hold them honestly: informative markers, not levers guaranteed to move outcomes when you push on them.
The insight everyone misses: the vessel lining is a living organ
Here is the part that reframes the whole topic, and once you see it the diet and lifestyle levers stop being a surprise. Every blood vessel is lined, on the inside, by a single layer of cells called the endothelium. It is not inert pipe -- it is one of the largest active tissues in the body, and its master signalling molecule is nitric oxide (NO), a gas the endothelium makes to tell the vessel to relax and widen. A well-functioning endothelial nitric oxide system keeps vessels supple and the lining healthy; when that system falters -- called endothelial dysfunction -- it is one of the earliest steps toward vascular trouble, before any plaque is visible.[7] This is the stage on which every marker above actually plays out: particles, inflammation and metabolic stress do their damage at the endothelium. This is also where the lipid panel and the blood-sugar story converge. Insulin resistance -- the thing the triglyceride-to-HDL ratio hints at -- directly shifts the endothelium's balance away from nitric oxide and toward constriction, degrading the lining's function.[8] So a high triglyceride-to-HDL ratio is not just a lipid pattern; it is a signal that the vessel lining itself is under pressure. And this is where minerals enter, through the sodium-to-potassium balance. Potassium supports the endothelium and healthy vascular tone, and raising potassium intake measurably lowers blood pressure -- pooled trials found increased potassium intake reduced systolic blood pressure, with the largest effect in people with hypertension.[9] Our modern diet inverts the ancestral ratio: heavy on sodium from processed food, light on potassium from plants. Our view: the Na:K balance is the most everyday lever on the endothelium there is -- less sodium from packaged food, more potassium from vegetables and fruit -- and it acts on the vessel lining, not just on a blood-pressure cuff reading.
Cardiovascular terms, explained
The cardiovascular conversation is full of abbreviations that hide how simple the logic underneath is. Here is the plain-language version of every term worth knowing, so the rest of the internet is easier to read.
- LDL-C (LDL cholesterol) -- an estimate of how much cholesterol CARGO is carried inside all your LDL particles combined. It is a measure of contents, not a count of particles, which is why it can read normal while the particle number is high.
- ApoB (apolipoprotein B) -- one molecule sits on every atherogenic particle (LDL, VLDL, IDL, Lp(a)), so a single ApoB test is a direct headcount of all the particles that can lodge in an artery wall. It counts the boats; LDL-C weighs the cargo.
- Lp(a) (lipoprotein(a)) -- an LDL-like particle set largely by your genes and mostly independent of diet and lifestyle. Worth measuring once to learn your inherited baseline; not something the diet-and-movement loop moves much.
- HDL-C (HDL cholesterol) -- cholesterol carried in HDL particles, involved in returning cholesterol from tissues. Higher is generally read as favourable, but like LDL-C it is a cargo measure, not the whole story.
- Triglycerides -- the main fat circulating in blood. High triglycerides often travel with insulin resistance and small, dense LDL particles.
- Triglyceride-to-HDL ratio -- triglycerides divided by HDL cholesterol, read as a proxy for insulin resistance. Both numbers are already on a standard panel, so the ratio is free information.
- hs-CRP (high-sensitivity C-reactive protein) -- a marker of low-grade inflammation, part of why atherosclerosis is an inflammatory process and not only a cholesterol one. Non-specific, so read as a trend in context.
- Homocysteine -- an amino acid cleared by methylation using B6, folate and B12; a high level is read partly as a methylation and B-vitamin-status signal. Informative, but lowering it has not reliably changed outcomes in trials.
- Endothelium -- the single-cell lining on the inside of every blood vessel. An active organ, not inert pipe; its health is where cardiovascular risk actually plays out.
- Nitric oxide (NO) -- the gas the endothelium makes to relax and widen vessels. Losing the ability to make enough of it -- endothelial dysfunction -- is an early step toward vascular trouble.
- Na:K balance -- the ratio of sodium to potassium in the diet. The modern diet is heavy on sodium and light on potassium, and shifting it back supports healthy blood pressure and the vessel lining.
The building blocks, described by what they do
With the logic in place, here is what each supporting lever actually does in the system. We describe these by mechanism and ingredient on purpose -- none treats, cures or prevents any cardiovascular condition, and none is a stand-alone fix. They are the raw materials healthy vessels and healthy metabolism run on. Omega-3 fats (EPA and DHA) are the most studied, and the honest reading is nuanced. High-dose EPA in people with elevated triglycerides was associated with fewer cardiovascular events in a large trial,[10] and omega-3 fats become part of the cell membranes that shape how the endothelium signals. But general omega-3 supplementation in broad, unselected populations has NOT consistently reduced cardiovascular events in meta-analysis.[11] So the fair summary is: omega-3s are foundational membrane and triglyceride nutrients with a real signal in the right context, not a magic pill for everyone -- and food-level intake from fatty fish is the sensible base. Potassium is the mineral lever on the Na:K balance and, through it, on blood pressure and the endothelium -- pooled trials show increased potassium intake lowers systolic blood pressure.[9] It comes, ideally, from vegetables and fruit rather than a pill. Dietary fiber lowers cardiovascular risk in its own right: pooling prospective studies, each additional 7 grams of daily fiber was associated with roughly a 9% lower risk of cardiovascular disease,[12] partly by improving the lipid and blood-sugar picture the triglyceride-to-HDL ratio tracks. Polyphenols -- the plant compounds in things like grape seed extract, cocoa and berries -- act on the endothelium and nitric-oxide side of the story, which is why colourful plants keep showing up in vascular research. Magnesium works alongside potassium in blood-pressure and vascular regulation. And CoQ10 sits in the energy machinery of the hard-working heart-muscle and vessel cells. A balanced multivitamin-and-mineral foundation (the kind of formula in LifePak) supplies several of these cofactors together in measured, food-level amounts, and a concentrated marine omega-3 (such as Marine Omega) is how some people reach an adequate EPA and DHA intake when fish is scarce in the diet. Our view: for the vessels specifically, the plant-forward plate -- potassium, fiber, polyphenols, omega-3 fats -- plus a sensible foundation beats any single isolated megadose.
What this looks like in real life
Theory is easy to nod along to and hard to act on, so here is the cell-out logic applied to ordinary situations. None of this diagnoses or treats anything -- it is the everyday version of supporting a system your body already runs, in order: read the fuller panel rather than one number, feed the endothelium and the metabolic side, and know the inherited risk you cannot change so you take the changeable parts more seriously. A note on the tools that make this doable: our free Diet Builder lets you load your plate with the potassium, fiber, omega-3 and polyphenol foods below and see what each one feeds, and the Daily 3-6-9 is nine minutes of movement, mind and meaning -- the movement-and-stress side matters directly here, because physical activity and calmer stress physiology both support endothelial nitric-oxide function.
- The "normal cholesterol, still worried" situation. If a standard panel came back with a fine LDL-C but heart disease runs in the family, the honest next step is to ask a clinician for the fuller picture -- ApoB to count the particles, Lp(a) once for the inherited baseline, and hs-CRP for inflammation -- because a high particle number or an inherited Lp(a) is invisible on LDL-C alone.[1][3] Then feed the endothelium from food: potassium and fiber from vegetables and fruit, omega-3 fats from fatty fish, and polyphenols from berries and cocoa. Use the Diet Builder to make those foods a habit rather than a one-off.
- The metabolic-first case. If triglycerides are creeping up and HDL is drifting down, calculate the triglyceride-to-HDL ratio yourself from the numbers already on your report -- a rising ratio points at insulin resistance, which degrades the vessel lining directly.[4][8] Here the first move is the blood-sugar side: fiber, movement, less ultra-processed food and less added sugar, not stacking supplements on top of an unaddressed metabolic pattern.
- The inherited-risk case. If an Lp(a) test comes back high, this is the one to handle with clear eyes: it is largely genetic and the diet-and-movement loop will not move it much.[3] The honest response is not despair and not a supplement chase -- it is to take every changeable lever (particle number, blood pressure, inflammation, metabolic health) more seriously, and to treat a high Lp(a) as a clinician conversation about your whole risk picture, not a number to self-manage.
The honest first moves: read the fuller panel, then close the loop
None of the above replaces the two steps that come before any supplement. Read the fuller panel, not one number. A normal LDL-C is a start, not an answer. If risk matters to you -- family history, a high triglyceride-to-HDL ratio, or just wanting the real picture -- that is the case for ApoB to count the particles, Lp(a) once for the inherited baseline, and hs-CRP for inflammation, interpreted by a clinician -- because the most common blind spot, a high particle number under a normal cholesterol, lives in exactly the value a standard panel never orders.[1][2] Then support the whole system, not just the cholesterol number. Cardiovascular health plays out at the endothelium -- the living vessel lining that runs on nitric oxide -- and that lining is shaped by the metabolic and mineral picture as much as by lipids.[7][8] So the levers are unglamorous and mostly cheap: the Na:K balance shifted toward potassium,[9] fiber,[12] omega-3 fats in the right context,[10] polyphenols, movement and calmer stress. Then re-measure, because a number you can watch change is the whole point of reading your labs. Our view, to close: the honest answer to "how do I read my cardiovascular labs" is that the labs are only as good as what you ask them to measure. A standard panel tells you roughly how much cholesterol cargo is in circulation. ApoB and Lp(a), plus a look at inflammation, the metabolic ratio and the endothelium, tell you how many particles you actually carry and how healthy the vessel lining handling them really is -- which is the question you came in with. Measure that, feed the system, and the cardiovascular conversation finally makes sense.
Key Takeaways
- The standard lipid panel's headline number, LDL-C, ESTIMATES how much cholesterol cargo is inside your LDL particles -- it does not COUNT the particles. Risk follows the number of atherogenic particles, so a normal LDL-C can sit on top of a high particle burden the panel never revealed.
- ApoB counts those particles directly (one ApoB per atherogenic particle) and predicts cardiovascular risk more consistently than LDL particle number when the two disagree. Lp(a) is a largely inherited, diet-independent particle a standard panel never orders -- worth measuring once for your baseline.
- The triglyceride-to-HDL ratio -- free from numbers already on your report -- reads as an insulin-resistance proxy; hs-CRP reads inflammation (a stronger event predictor than LDL in one large cohort); homocysteine reads methylation and B-vitamin status, though lowering it has not reliably changed outcomes.
- The mechanism that ties it together is the endothelium -- the single-cell vessel lining that runs on nitric oxide. Insulin resistance degrades it, and the sodium-to-potassium balance is an everyday lever on it: more potassium from plants lowers blood pressure and supports the lining.
- The first moves come before any supplement: read the fuller panel (ApoB, Lp(a), hs-CRP) rather than one number, and close the loop -- potassium, fiber, omega-3 in context, polyphenols, movement -- then re-measure. Omega-3 and homocysteine-lowering are held honestly, not oversold.
Sources
Powered by CellWell.life- 1.Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank (2025)
- 2.Concordance-discordance between apolipoprotein B and lipid biomarkers in predicting 20-year atherosclerotic cardiovascular disease risk: The ATTICA study (2025)
- 3.Lipoprotein(a): from Causality to Treatment (2024)
- 4.Use of Metabolic Markers to Identify Overweight Individuals Who Are Insulin Resistant (2003)
- 5.C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women (2000)
- 6.Effects of B Vitamins on Homocysteine Lowering and Thrombotic Risk Reduction -- A Review of Randomized Controlled Trials (2024)
- 7.Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace (2006)
- 8.Role of Insulin Resistance in Endothelial Dysfunction (2013)
- 9.Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses (2013)
- 10.Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT, 2019)
- 11.Omega-3 supplementation and cardiovascular disease: meta-analysis (2012)
- 12.Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis (2013)
- 13.Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease (HOPE-2, 2006)
Related
Want the next one of these?
The Signal is one email when there is something genuinely worth your attention -- written the way this post is, in plain language, with the studies behind it. No noise, no selling your address, and nothing to buy.
The Signal, and nothing else -- no fixed schedule, only when there is something worth sending. We never sell or share your address, and you can unsubscribe in one click any time.